Page last updated: 2024-10-25

debrisoquin and Chemical and Drug Induced Liver Injury

debrisoquin has been researched along with Chemical and Drug Induced Liver Injury in 5 studies

Debrisoquin: An adrenergic neuron-blocking drug similar in effects to GUANETHIDINE. It is also noteworthy in being a substrate for a polymorphic cytochrome P-450 enzyme. Persons with certain isoforms of this enzyme are unable to properly metabolize this and many other clinically important drugs. They are commonly referred to as having a debrisoquin 4-hydroxylase polymorphism.

Chemical and Drug Induced Liver Injury: A spectrum of clinical liver diseases ranging from mild biochemical abnormalities to ACUTE LIVER FAILURE, caused by drugs, drug metabolites, herbal and dietary supplements and chemicals from the environment.

Research Excerpts

ExcerptRelevanceReference
"We report on a case of perhexiline maleate-induced hepatitis secondary to a long-term administration of recommended daily dosages of 300 mg."1.28Perhexiline maleate-induced hepatitis. ( Maurer, R; Satz, N; Spycher, MA; Streuli, R; Täuber, M, 1991)
"Perhexiline maleate is an antianginal agent which depends on hepatic oxidation for its elimination."1.27Impaired oxidation of debrisoquine in patients with perhexiline liver injury. ( Morgan, MY; Oates, NS; Reshef, R; Shah, RR; Sherlock, S; Smith, RL, 1984)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19902 (40.00)18.7374
1990's2 (40.00)18.2507
2000's0 (0.00)29.6817
2010's1 (20.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Warner, DJ1
Chen, H1
Cantin, LD1
Kenna, JG1
Stahl, S1
Walker, CL1
Noeske, T1
Morgan, MY1
Reshef, R1
Shah, RR1
Oates, NS1
Smith, RL1
Sherlock, S1
Satz, N1
Täuber, M1
Streuli, R1
Spycher, MA1
Maurer, R1
Toutoungi, M1
Magnenat, D1
Larrey, D1
Henrion, J1
Heller, F1
Babany, G1
Degott, C1
Pessayre, D1
Benhamou, JP1

Other Studies

5 other studies available for debrisoquin and Chemical and Drug Induced Liver Injury

ArticleYear
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters

2012
Impaired oxidation of debrisoquine in patients with perhexiline liver injury.
    Gut, 1984, Volume: 25, Issue:10

    Topics: Adolescent; Adult; Aged; Angina Pectoris; Chemical and Drug Induced Liver Injury; Chronic Disease; D

1984
Perhexiline maleate-induced hepatitis.
    Hepato-gastroenterology, 1991, Volume: 38, Issue:4

    Topics: Angina Pectoris; Biopsy; Chemical and Drug Induced Liver Injury; Debrisoquin; Humans; Liver; Male; M

1991
Lack of defect in oxidative hydroxylation of debrisoquine in a patient with halothane hepatitis.
    European journal of clinical pharmacology, 1990, Volume: 38, Issue:6

    Topics: Adult; Chemical and Drug Induced Liver Injury; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme Syst

1990
Metoprolol-induced hepatitis: rechallenge and drug oxidation phenotyping.
    Annals of internal medicine, 1988, Volume: 108, Issue:1

    Topics: Chemical and Drug Induced Liver Injury; Debrisoquin; Female; Humans; Liver Function Tests; Metoprolo

1988